VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30067560 | HIV | ENSG00000106258.16 | protein_coding | CYP3A5 | No | No | 1577 | P20815 |
TVIS30067561 | HIV | ENSG00000106258.16 | protein_coding | CYP3A5 | No | No | 1577 | P20815 |
TVIS30067562 | HIV | ENSG00000106258.16 | protein_coding | CYP3A5 | No | No | 1577 | P20815 |
TVIS30067563 | HIV | ENSG00000106258.16 | protein_coding | CYP3A5 | No | No | 1577 | P20815 |
TVIS44050640 | HTLV-1 | ENSG00000106258.16 | protein_coding | CYP3A5 | No | No | 1577 | P20815 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | CYP3A5 |
---|---|
DrugBank ID | DB09065 |
Drug Name | Cobicistat |
Target ID | BE0002362 |
UniProt ID | P20815 |
Regulation Type | inhibitor |
PubMed IDs | 20043009; 28627229 |
Citations | Mathias AA, German P, Murray BP, Wei L, Jain A, West S, Warren D, Hui J, Kearney BP: Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther. 2010 Mar;87(3):322-9. doi: 10.1038/clpt.2009.228. Epub 2009 Dec 30.@@Tseng A, Hughes CA, Wu J, Seet J, Phillips EJ: Cobicistat Versus Ritonavir: Similar Pharmacokinetic Enhancers But Some Important Differences. Ann Pharmacother. 2017 Nov;51(11):1008-1022. doi: 10.1177/1060028017717018. Epub 2017 Jun 19. |
Groups | Approved |
Direct Classification | N-carbamoyl-alpha amino acids and derivatives |
SMILES | CC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1 |
Pathways | |
PharmGKB | PA166165092 |
ChEMBL | CHEMBL2095208 |